On Friday, Chief Judge Stark issued his opinion on post-trial motions in Pacific Biosciences of California, Inc. v. Oxfore Nanopore Tech., Inc., C.A. No. 17-275-LPS-CJB (D. Del.).
You may remember it as the case which made news at the time due in part to the mention of coronavirus in the opening statements.
The trial took place March 9-18, just as the first COVID-19 lock downs were ramping up.
Incredibly, both parties touted coronavirus-related effects of their products in their opening statements at trial. Plaintiff suggested that its product could "help develop a vaccine" for the coronavirus. Defendant went even further:
[Defendant made] a product that is changing lives as we speak. Whether it is helping people …